Translational and Clinical Pharmacology
Leino Lab

Transforming Drug Therapy Through Individualized Dosing

The dose of medication a person receives is an important determinant of whether they experience efficacy, toxicity, or no effect at all. Most medications use a “one-size-fits-all" approach to determine the dose based on the experience of the average person in clinical trials. For some drugs, this works fine but for others it can mean the medication is not effective or side effects are common.

Our lab believes there are many examples where more precise dosing can benefit patients, particularly children who are still growing. Our mission is to improve dosing for medications that have

  1. a narrow therapeutic index (the difference between efficacy and toxicity is small),
  2. large variability between people in the way the body handles the drug (known as pharmacokinetics) and responds to the drug (known as pharmacodynamics), or
  3. changes in drug exposure or response over time despite receiving the same dose.

Transplant medications meet all these criteria so much of our work involves people who have received a transplant.  

Precision dosing uses drug characteristics, disease knowledge, and person-specific factors to optimize drug therapy. Tailoring the dose based on this information increases the chance of treatment success while minimizing the risk of toxicity. However, much of this information must be gathered from the person taking the medication by measuring levels in the blood—sometimes repeatedly — or asking questions about how and when the medication is taken.

A graph explaining precision dosing.

Our lab wants to find ways to make gathering this information as quick and painless as possible using new technology. For some drugs this means using self-collected samples or identifying a new biomarker that predicts the drug exposure-response or using mobile technology to gather environmental information. The data can then be used to develop mathematical models or algorithms that can provide dosing recommendations tailored to the individual.

In addition, we want to create systems of drug dosing that are easy to use and meet the needs of patients, caregivers, and their healthcare providers so the lab also uses implementation science to study factors that may improve success such as social support or providing education.

About the PI

Abbie Pharmd

Abbie Leino, PharmD, PhD

I am an assistant professor in the Division of Translational and Clinical Pharmacology and principal investigator for the Leino Lab.  With more than 10 years of experience as a clinical pharmacist, my work focuses on improving medication dosing in ways that make sense in the real world. I’m excited to lead the team to help accelerate the clinical implementation of excellent science on precision dosing to improve the lives of children who need medications.

View My Full Web Bio